Literature DB >> 19759191

Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion.

D Wu1, L Chen1, W Liao2, Y Ding3, Q Zhang3, Z Li3, L Liu4.   

Abstract

BACKGROUND: The purpose of this study was to investigate prognostic significance of fascin1 in nasopharyngeal carcinoma (NPC) and evaluate the association of fascin1 with tumor invasion.
MATERIALS AND METHODS: Immunohistochemical staining for fascin1 was carried out on paraffin-embedded tissue sections from 161 patients with NPC. Data were subjected to statistical analysis with respect to clinicopathological variables and survival. Small interfering RNA (siRNA) approach was used to knockdown fascin1 expression in NPC cells to determine whether fascin1 contributes to tumor cell invasion.
RESULTS: Immunohistochemical analysis showed that fascin1 was highly expressed in 95 (59.0%) of 161 paraffin-embedded NPC tissues. Fascin1 expression was significantly correlated with clinical stage (P < 0.001) and N classification (P < 0.001). Statistical analysis showed that fascin1 expression was inversely correlated with both overall and disease-free survival of NPC patients. Multivariate analysis showed that fascin1 expression was an independent prognostic indicator for patient's survival. Moreover, disruption of endogenous fascin1 expression in NPC cells using siRNA technique suppressed NPC cell invasiveness and decreased cell filopodia and lamellopodia.
CONCLUSION: The present study indicates that fascin1 expression is inversely correlated with NPC patient survival and directly correlated with the malignant status of NPC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759191     DOI: 10.1093/annonc/mdp333

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  9 in total

1.  miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition.

Authors:  Hong Zhao; Xing Kang; Xuefeng Xia; Like Wo; Xidong Gu; Yuanyuan Hu; Xiaohong Xie; Helena Chang; Lihua Lou; Xuning Shen
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 2.  FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.

Authors:  Zhongxun Li; Jiao Shi; Nannan Zhang; Xiwang Zheng; Yukun Jin; Shuxin Wen; Wanglai Hu; Yongyan Wu; Wei Gao
Journal:  J Cancer       Date:  2022-05-09       Impact factor: 4.478

3.  Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.

Authors:  Yi Qin; Zhi-Wei Liao; Jing-Yan Luo; Wen-Zhe Wu; An-Shang Lu; Pu-Xia Su; Bing-Quan Lai; Xiao-Xiao Wang
Journal:  Tumour Biol       Date:  2016-01-15

4.  Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.

Authors:  Zheng-sheng Wu; Chao-qun Wang; Ru Xiang; Xue Liu; Shan Ye; Xue-qing Yang; Gui-hong Zhang; Xiao-chun Xu; Tao Zhu; Qiang Wu
Journal:  BMC Cancer       Date:  2012-02-01       Impact factor: 4.430

5.  MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma.

Authors:  Ying-Qin Li; Qing-Mei He; Xian-Yue Ren; Xin-Ran Tang; Ya-Fei Xu; Xin Wen; Xiao-Jing Yang; Jun Ma; Na Liu
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

6.  Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis.

Authors:  Cong Chen; Bojian Xie; Zhaoqing Li; Lini Chen; Yongxia Chen; Jichun Zhou; Siwei Ju; Yulu Zhou; Xun Zhang; Wenying Zhuo; Jingjing Yang; Misha Mao; Ling Xu; Linbo Wang
Journal:  Cell Death Dis       Date:  2022-02-14       Impact factor: 8.469

7.  Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer.

Authors:  Wei Zhao; Jing Gao; Jing Wu; Qiu-Hong Liu; Zhi-Gang Wang; Hui-Ling Li; Li-Hua Xing
Journal:  Onco Targets Ther       Date:  2015-09-15       Impact factor: 4.147

8.  Fascin upregulation in primary head and neck squamous cell carcinoma is associated with lymphatic metastasis.

Authors:  Konstantinos Papaspyrou; Christoph Brochhausen; Irene Schmidtmann; Kai Fruth; Haralampos Gouveris; James Kirckpatrick; Wolf Mann; Juergen Brieger
Journal:  Oncol Lett       Date:  2014-03-28       Impact factor: 2.967

9.  MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.

Authors:  Ying-Qing Li; Jian-Hua Lu; Xue-Ming Bao; Xi-Fu Wang; Jun-Hua Wu; Wei-Qiang Hong
Journal:  J Exp Clin Cancer Res       Date:  2015-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.